|
⚲
|
| Keyboard |
| Nanoviricides Inc
✚
|
|
|---|---|
| CIK # | 0001379006 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001379006] | |
| 10-Q | [0001379006] | |
| 3 | [0001379006] | |
| 4 | [0001379006] | |
| 8-K | [0001379006] | |
| D | [0001379006] | |
| SC 13D | [0001379006] | |
| SC 13G | [0001379006] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Altium Capital Management LP | Nanoviricides Inc | [2020-07-20] |
| CVI Investments Inc | Nanoviricides Inc | [2020-05-29] |
| Empery Asset Management LP | Nanoviricides Inc | [2020-01-27] |
| Boniuk Milton | Nanoviricides Inc | [2018-10-12] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Boniuk Milton | |
| Nanoviricides Inc | |
| Diwan Anil | |
| Jawadakar Makarand | |
| Day Mark D | |
| Seymour Eugene | |
| Vyas Meeta | |
| Kulkarni Mukund S | |
| Theracour Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2022-08-08 | Gift | 94,471 | $0.00 | |
|
Nanoviricides Inc NNVC
10% Coupon Series C Convertible Debenture · derivative
|
2018-05-21 | Option exercise | $5,000,000.00 | ||
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2018-05-21 | Option exercise | 5,500,000 | ||
|
Nanoviricides Inc NNVC
Series A Conv Pref Stock, par value $0.001 per share · derivative
|
2018-05-21 | Grant | $0.00 | ||
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2017-07-11 | Grant | 120,744 | ||
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2017-05-04 | Grant | 149,478 | ||
|
Nanoviricides Inc NNVC
8% Coupon Series B Convertible Debenture · derivative
|
2017-02-21 | Option exercise | 150,000 | $2,000,000.00 | 300,000,000,000 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2017-02-21 | Grant | 153,611 | ||
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2017-02-21 | Option exercise | 1,746,288 | ||
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2017-02-01 | Other | 605,474 | $0.00 | |
|
Nanoviricides Inc NNVC
Unsecured 8% Coupon Series B Convertible Debentures · derivative
|
2017-02-01 | Other | 1 | $0.00 | |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-05-19 | Grant | 25,000 | $1.50 | 37,500 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-05-12 | Grant | 25,000 | $1.50 | 37,500 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-05-04 | Grant | 14,991 | $1.68 | 25,185 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-04-29 | Grant | 2,900 | $1.68 | 4,872 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-04-28 | Grant | 7,109 | $1.68 | 11,943 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-04-27 | Grant | 25,000 | $1.78 | 44,500 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-02-18 | Grant | 9,000 | $1.70 | 15,300 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-02-12 | Grant | 141,844 | $1.18 | 167,376 |
|
Nanoviricides Inc NNVC
Common Stock, par value $0.001 per share
|
2016-02-12 | Grant | 34,043 | $1.18 | 40,171 |
| showing 20 of 100 most recent transactions | |||||